These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 29447848)
21. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate. Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228 [TBL] [Abstract][Full Text] [Related]
22. Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion. Bhardwaj V; Trasi NS; Zemlyanov DY; Taylor LS Int J Pharm; 2018 Apr; 540(1-2):106-119. PubMed ID: 29425762 [TBL] [Abstract][Full Text] [Related]
23. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization. Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256 [TBL] [Abstract][Full Text] [Related]
24. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier. Ghanavati R; Taheri A; Homayouni A Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614 [TBL] [Abstract][Full Text] [Related]
25. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707 [TBL] [Abstract][Full Text] [Related]
26. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions. Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151 [TBL] [Abstract][Full Text] [Related]
27. [Study on the properties of felodipine solid dispersions prepared by different technologies]. Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515 [TBL] [Abstract][Full Text] [Related]
28. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898 [TBL] [Abstract][Full Text] [Related]
29. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions. Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899 [TBL] [Abstract][Full Text] [Related]
30. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Madsen CM; Boyd B; Rades T; Müllertz A Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089 [TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. Vora C; Patadia R; Mittal K; Mashru R Pharm Dev Technol; 2016 Nov; 21(7):847-855. PubMed ID: 26333427 [TBL] [Abstract][Full Text] [Related]
32. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine. Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654 [TBL] [Abstract][Full Text] [Related]
33. Hot-melt extrusion for enhanced delivery of drug particles. Miller DA; McConville JT; Yang W; Williams RO; McGinity JW J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869 [TBL] [Abstract][Full Text] [Related]
34. Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions. Knopp MM; Nguyen JH; Mu H; Langguth P; Rades T; Holm R AAPS J; 2016 Mar; 18(2):416-23. PubMed ID: 26769250 [TBL] [Abstract][Full Text] [Related]
35. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers. Ojo AT; Ma C; Lee PI Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149 [TBL] [Abstract][Full Text] [Related]
36. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. Andrews GP; AbuDiak OA; Jones DS J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757 [TBL] [Abstract][Full Text] [Related]
37. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes. Tiwari R; Gupta A; Joshi M; Tiwari G PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601 [TBL] [Abstract][Full Text] [Related]
38. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine. Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832 [TBL] [Abstract][Full Text] [Related]
39. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers. Dhumal RS; Shimpi SL; Paradkar AR Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109 [TBL] [Abstract][Full Text] [Related]
40. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]